ISCN.F Stock Overview
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Isracann Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.02 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.99% |
| 33 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ISCN.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 0.9% |
| 1Y | -100.0% | 21.0% | 32.3% |
Return vs Industry: ISCN.F underperformed the US Pharmaceuticals industry which returned 21% over the past year.
Return vs Market: ISCN.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| ISCN.F volatility | |
|---|---|
| ISCN.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ISCN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ISCN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Ajay Kaila | www.isracann.com |
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany.
Isracann Biosciences Inc. Fundamentals Summary
| ISCN.F fundamental statistics | |
|---|---|
| Market cap | US$176.00 |
| Earnings (TTM) | -US$3.36m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ISCN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISCN.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$4.54m |
| Earnings | -CA$4.54m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ISCN.F perform over the long term?
See historical performance and comparison